Advertisement
Screener

OMEROS CORP (OMER) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

OMEROS CORP Operating Cash Flow

OMEROS CORP (OMER) reported Operating Cash Flow of -$10.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12

  • OMEROS CORP net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $4.15M.
  • OMEROS CORP net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$14.51M.
  • OMEROS CORP net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$39.84M.
  • OMEROS CORP net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$18.47M.
  • OMEROS CORP net cash provided by (used in) operating activities for fiscal 2025 was -$116.09M.
  • OMEROS CORP net cash provided by (used in) operating activities for fiscal 2024 was -$148.80M, a 299.13% decline from fiscal 2023.
  • OMEROS CORP net cash provided by (used in) operating activities for fiscal 2023 was $74.73M.
  • OMEROS CORP net cash provided by (used in) operating activities for fiscal 2022 was -$86.48M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 204 monthNet Cash Provided by (Used in) Operating Activities 207 month
2026-06-30$4.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$10.36M
10-Q · filed 2026-08-12
-$50.20M
derived: sum of 3 quarters · filed 2026-08-12
-$68.67M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$14.51M
10-Q · filed 2026-05-13
-$54.35M
derived: sum of 2 quarters · filed 2026-05-13
-$72.82M
derived: sum of 3 quarters · filed 2026-05-13
-$94.76M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$39.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$58.31M
derived: sum of 2 quarters · filed 2026-03-31
-$80.25M
derived: sum of 3 quarters · filed 2026-08-12
-$116.09M
10-K · filed 2026-03-31
2025-09-30-$18.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$40.41M
derived: sum of 2 quarters · filed 2026-08-12
-$76.25M
10-Q · filed 2025-11-13
-$105.23M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$21.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$57.78M
10-Q · filed 2026-08-12
-$86.76M
derived: sum of 3 quarters · filed 2026-08-12
-$118.82M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$35.84M
10-Q · filed 2026-05-13
-$64.82M
derived: sum of 2 quarters · filed 2026-05-13
-$96.88M
derived: sum of 3 quarters · filed 2026-05-13
-$142.86M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$28.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$61.04M
derived: sum of 2 quarters · filed 2026-03-31
-$107.02M
derived: sum of 3 quarters · filed 2026-03-31
-$148.80M
10-K · filed 2026-03-31
2024-09-30-$32.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$78.04M
derived: sum of 2 quarters · filed 2025-11-13
-$119.82M
10-Q · filed 2025-11-13
-$154.65M
derived: sum of 4 quarters · filed 2026-03-31
2024-06-30-$45.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$87.77M
10-Q · filed 2025-08-14
-$122.59M
derived: sum of 3 quarters · filed 2026-03-31
-$155.24M
derived: sum of 4 quarters · filed 2026-03-31
2024-03-31-$41.78M
10-Q · filed 2025-05-15
-$76.61M
derived: sum of 2 quarters · filed 2026-03-31
-$109.25M
derived: sum of 3 quarters · filed 2026-03-31
-$141.59M
derived: sum of 4 quarters · filed 2026-03-31
2023-12-31-$34.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$67.47M
derived: sum of 2 quarters · filed 2026-03-31
-$99.81M
derived: sum of 3 quarters · filed 2026-03-31
$74.73M
10-K · filed 2026-03-31
2023-09-30-$32.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$64.99M
derived: sum of 2 quarters · filed 2024-11-13
$109.55M
10-Q · filed 2024-11-13
$84.17M
derived: sum of 4 quarters · filed 2025-03-31
2023-06-30-$32.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$142.20M
10-Q · filed 2024-08-07
$116.82M
derived: sum of 3 quarters · filed 2025-03-31
$90.38M
derived: sum of 4 quarters · filed 2025-03-31
2023-03-31$174.54M
10-Q · filed 2024-05-15
$149.16M
derived: sum of 2 quarters · filed 2025-03-31
$122.72M
derived: sum of 3 quarters · filed 2025-03-31
$103.25M
derived: sum of 4 quarters · filed 2025-03-31
2022-12-31-$25.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$51.82M
derived: sum of 2 quarters · filed 2025-03-31
-$71.29M
derived: sum of 3 quarters · filed 2025-03-31
-$86.48M
10-K · filed 2025-03-31
2022-09-30-$26.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$45.91M
derived: sum of 2 quarters · filed 2023-11-09
-$61.10M
10-Q · filed 2023-11-09
-$79.32M
derived: sum of 4 quarters · filed 2024-04-01
2022-06-30-$19.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$34.66M
10-Q · filed 2023-08-09
-$52.88M
derived: sum of 3 quarters · filed 2024-04-01
-$76.54M
derived: sum of 4 quarters · filed 2024-04-01
2022-03-31-$15.19M
10-Q · filed 2023-05-09
-$33.41M
derived: sum of 2 quarters · filed 2024-04-01
-$57.07M
derived: sum of 3 quarters · filed 2024-04-01
-$84.66M
derived: sum of 4 quarters · filed 2024-04-01
2021-12-31-$18.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$41.88M
derived: sum of 2 quarters · filed 2024-04-01
-$69.47M
derived: sum of 3 quarters · filed 2024-04-01
-$109.72M
10-K · filed 2024-04-01
2021-09-30-$23.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$51.25M
derived: sum of 2 quarters · filed 2022-11-09
-$91.51M
10-Q · filed 2022-11-09
-$109.91M
derived: sum of 4 quarters · filed 2023-03-13
2021-06-30-$27.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$67.85M
10-Q · filed 2022-08-09
-$86.25M
derived: sum of 3 quarters · filed 2023-03-13
-$121.19M
derived: sum of 4 quarters · filed 2023-03-13
2021-03-31-$40.25M
10-Q · filed 2022-05-10
-$58.66M
derived: sum of 2 quarters · filed 2023-03-13
-$93.60M
derived: sum of 3 quarters · filed 2023-03-13
-$131.20M
derived: sum of 4 quarters · filed 2023-03-13
2020-12-31-$18.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
-$53.35M
derived: sum of 2 quarters · filed 2023-03-13
-$90.94M
derived: sum of 3 quarters · filed 2023-03-13
-$100.09M
10-K · filed 2023-03-13
2020-09-30-$34.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$72.54M
derived: sum of 2 quarters · filed 2021-11-09
-$81.68M
10-Q · filed 2021-11-09
-$104.69M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$37.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$46.74M
10-Q · filed 2021-08-09
-$69.75M
derived: sum of 3 quarters · filed 2022-03-01
-$77.27M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$9.14M
10-Q · filed 2021-05-10
-$32.16M
derived: sum of 2 quarters · filed 2022-03-01
-$39.68M
derived: sum of 3 quarters · filed 2022-03-01
-$56.27M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$23.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$30.54M
derived: sum of 2 quarters · filed 2022-03-01
-$47.13M
derived: sum of 3 quarters · filed 2022-03-01
-$60.07M
10-K · filed 2022-03-01
2019-09-30-$7.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$24.11M
derived: sum of 2 quarters · filed 2020-11-09
-$37.06M
10-Q · filed 2020-11-09
-$61.72M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$16.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$29.54M
10-Q · filed 2020-08-10
-$54.19M
derived: sum of 3 quarters · filed 2021-03-01
-$91.07M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$12.95M
10-Q · filed 2020-05-11
-$37.60M
derived: sum of 2 quarters · filed 2021-03-01
-$74.48M
derived: sum of 3 quarters · filed 2021-03-01
-$105.39M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$24.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$61.53M
derived: sum of 2 quarters · filed 2021-03-01
-$92.44M
derived: sum of 3 quarters · filed 2021-03-01
-$103.74M
10-K · filed 2021-03-01
2018-09-30-$36.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$67.78M
derived: sum of 2 quarters · filed 2019-11-12
-$79.08M
10-Q · filed 2019-11-12
-$83.25M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$30.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$42.21M
10-Q · filed 2019-08-08
-$46.38M
derived: sum of 3 quarters · filed 2020-03-02
-$57.57M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$11.30M
10-Q · filed 2019-05-09
-$15.47M
derived: sum of 2 quarters · filed 2020-03-02
-$26.66M
derived: sum of 3 quarters · filed 2020-03-02
-$34.82M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$4.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$15.37M
derived: sum of 2 quarters · filed 2020-03-02
-$23.52M
derived: sum of 3 quarters · filed 2020-03-02
-$36.23M
10-K · filed 2020-03-02
2017-09-30-$11.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$19.35M
derived: sum of 2 quarters · filed 2018-11-08
-$32.05M
10-Q · filed 2018-11-08
-$42.92M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$8.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$20.86M
10-Q · filed 2018-08-09
-$31.72M
derived: sum of 3 quarters · filed 2019-03-01
-$42.94M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$12.70M
10-Q · filed 2018-05-10
-$23.57M
derived: sum of 2 quarters · filed 2019-03-01
-$34.78M
derived: sum of 3 quarters · filed 2019-03-01
-$47.58M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$10.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$22.08M
derived: sum of 2 quarters · filed 2019-03-01
-$34.88M
derived: sum of 3 quarters · filed 2019-03-01
-$51.50M
10-K · filed 2019-03-01
2016-09-30-$11.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$24.01M
derived: sum of 2 quarters · filed 2017-11-09
-$40.64M
10-Q · filed 2017-11-09
-$57.24M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$12.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$29.42M
10-Q · filed 2017-08-08
-$46.02M
derived: sum of 3 quarters · filed 2018-03-01
-$60.61M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$16.63M
10-Q · filed 2017-05-10
-$33.23M
derived: sum of 2 quarters · filed 2018-03-01
-$47.82M
derived: sum of 3 quarters · filed 2018-03-01
-$64.36M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$16.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
-$31.19M
derived: sum of 2 quarters · filed 2018-03-01
-$47.73M
derived: sum of 3 quarters · filed 2018-03-01
-$65.21M
10-K · filed 2018-03-01
2015-09-30-$14.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$31.13M
derived: sum of 2 quarters · filed 2016-11-09
-$48.61M
10-Q · filed 2016-11-09
-$64.30M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$16.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$34.02M
10-Q · filed 2016-08-09
-$49.71M
derived: sum of 3 quarters · filed 2017-03-16
-$65.65M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31-$17.48M
10-Q · filed 2016-05-10
-$33.17M
derived: sum of 2 quarters · filed 2017-03-16
-$49.11M
derived: sum of 3 quarters · filed 2017-03-16
-$64.38M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31-$15.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$31.63M
derived: sum of 2 quarters · filed 2017-03-16
-$46.91M
derived: sum of 3 quarters · filed 2017-03-16
-$58.04M
10-K · filed 2017-03-16
2014-09-30-$15.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$31.21M
derived: sum of 2 quarters · filed 2015-11-09
-$42.35M
10-Q · filed 2015-11-09
-$42.65M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30-$15.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$26.41M
10-Q · filed 2015-08-10
-$26.71M
derived: sum of 3 quarters · filed 2016-03-15
-$37.74M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$11.14M
10-Q · filed 2015-05-11
-$11.44M
derived: sum of 2 quarters · filed 2016-03-15
-$22.47M
derived: sum of 3 quarters · filed 2016-03-15
-$31.87M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31-$296.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$11.33M
derived: sum of 2 quarters · filed 2016-03-15
-$20.73M
derived: sum of 3 quarters · filed 2016-03-15
-$29.70M
10-K · filed 2016-03-15
2013-09-30-$11.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$20.43M
derived: sum of 2 quarters · filed 2014-11-10
-$29.40M
10-Q · filed 2014-11-10
-$42.18M
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30-$9.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$18.36M
10-Q · filed 2014-08-11
-$31.14M
derived: sum of 3 quarters · filed 2015-03-16
-$38.55M
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31-$8.97M
10-Q · filed 2014-05-12
-$21.75M
derived: sum of 2 quarters · filed 2015-03-16
-$29.15M
derived: sum of 3 quarters · filed 2015-03-16
-$38.01M
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31-$12.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
-$20.18M
derived: sum of 2 quarters · filed 2015-03-16
-$29.05M
derived: sum of 3 quarters · filed 2015-03-16
-$34.55M
10-K · filed 2015-03-16
2012-09-30-$7.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$16.26M
derived: sum of 2 quarters · filed 2013-11-07
-$21.77M
10-Q · filed 2013-11-07
-$29.13M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30-$8.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$14.37M
10-Q · filed 2013-08-09
-$21.73M
derived: sum of 3 quarters · filed 2014-03-13
-$25.83M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31-$5.50M
10-Q · filed 2013-05-09
-$12.87M
derived: sum of 2 quarters · filed 2014-03-13
-$16.97M
derived: sum of 3 quarters · filed 2014-03-13
-$23.30M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31-$7.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
-$11.47M
derived: sum of 2 quarters · filed 2014-03-13
-$17.79M
derived: sum of 3 quarters · filed 2014-03-13
-$25.67M
10-K · filed 2014-03-13
2011-09-30-$4.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$10.43M
derived: sum of 2 quarters · filed 2012-11-09
-$18.31M
10-Q · filed 2012-11-09
-$11.69M
derived: sum of 4 quarters · filed 2013-03-18
-$121.11M
10-Q · filed 2011-11-08
2011-06-30-$6.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$14.20M
10-Q · filed 2012-08-07
-$7.58M
derived: sum of 3 quarters · filed 2013-03-18
-$13.48M
derived: sum of 4 quarters · filed 2013-03-18
-$117.01M
10-Q · filed 2011-08-09
2011-03-31-$7.88M
10-Q · filed 2012-05-10
-$1.25M
derived: sum of 2 quarters · filed 2013-03-18
-$7.15M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$6.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$724.00K
derived: sum of 2 quarters · filed 2013-03-18
-$14.50M
10-K · filed 2013-03-18
2010-09-30-$5.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
-$21.12M
10-Q · filed 2011-11-08
2010-06-30-$15.23M
10-Q · filed 2011-08-09
2009-12-31-$19.03M
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82